Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02270463
Title SL-401 as Consolidation Therapy in Patients With Adverse Risk Acute Myeloid Leukemia in First Complete Remission
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Stemline Therapeutics, Inc.
Indications

acute myeloid leukemia

Therapies

Tagraxofusp-erzs

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 12902 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Albert Einstein College of Medicine Bronx New York 10461 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
M.D. Anderson Cancer Center Houston Texas 77030 United States Details
Fred Hutchinson Cancer Research Institute Seattle Washington 98101 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field